Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

TrxR inhibitor Au-24 shows promise in vivo and in vitro for treating hepatocellular carcinoma

May 30, 2022

Broadenbio synthesizes new MAP4K1 inhibitors

May 30, 2022

Betta Pharmaceuticals identifies new IDH inhibitors

May 30, 2022

Tyligand Bioscience divulges GTPase KRAS mutant inhibitors

May 30, 2022

Shanghai Yao Biotech discloses new TRK inhibitors

May 30, 2022

Forma Therapeutics introduces USP1 inhibitor FT-3171

May 27, 2022

Discovery of novel microtubule targeting agent for the treatment of cancer

May 27, 2022

NHLBI grant supports IND-enabling studies of NMX-1 for triple-negative breast cancer

May 27, 2022

New NFE2L2 activators identified by Sitryx Therapeutics

May 27, 2022

Lengo Therapeutics presents new EGFR and HER2 inhibitors

May 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...